S. Yeh

N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.

W. Gerald, J. Mora, G. Heller, 2001, Medical and pediatric oncology.

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.

W. Gerald, S. Larson, N. Cheung, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8.

J. Humm, R. Finn, K. Kramer, 2000, Medical and pediatric oncology.

Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.

W. Gerald, G. Heller, M. LaQuaglia, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.

S. Larson, N. Cheung, G. Heller, 1994, Cancer research.

3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study.

N. Cheung, B. Kushner, S. Yeh, 1994, Progress in clinical and biological research.

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma.

S. Larson, F. Real, M. Kris, 1991, Journal of the National Cancer Institute.